Latest Articles

Despite the global shift toward early detection and prevention in oncology, oral cancer is still treated reactively. This article explores the emerging potential of light-based therapies that can be used in non-hospital settings.

Federated data platforms offer a solution to many of the challenges associated with advancing precision medicine with artificial intelligence.

In this Q&A, Dr. Seshadhri Subramanian of UEA discusses new research linking specific urinary and prostatic bacteria to aggressive prostate cancer. The team identified a bacterial biomarker set associated with faster disease progression.

In this third installment of our miniseries, we explore the contrasting roles of harmful and protective dietary components – such as the Western diet and red meat versus dietary fiber and polyphenols – on gut health and cancer development.

Discover how cutting-edge tools and analytics are advancing cell therapy, improving precision, safety and scalability in modern treatments.

For this article, Technology Networks asked a diverse group of academics and industry leaders: How should research funding change to better support innovation? Here’s how current models help – or hinder – their work.

Experts discuss how academic publishing must change to support open science, transparency and global accessibility in a digital-first research world.

This article explores the relationship between the immune system and cancer and outlines therapeutic strategies that leverage a patient’s immune system to treat cancer.

Could what's on your plate change your chemo outcome? Dietary microRNAs from food like eggs could affect cancer drug response – here’s what in silico analysis reveals about this promising discovery.

Technology Networks recently had the pleasure of interviewing Dr. Tyler Brown, founder, president and chair of OUTbio San Diego, to learn more about the organization’s origins, rapid growth and mission to create lasting impact.